Amendment No.40 to Paragraph 3
3. Notes that the European Medicines Agency (EMA) is a largely fee-funded agency, with 89.78% of its 2024 C1 revenue stemming from fees paid by the pharmaceutical industry for services provided....
MEP
Europe of Sovereign Nations
Germany (Alternative für Deutschland)
3. Notes that the European Medicines Agency (EMA) is a largely fee-funded agency, with 89.78% of its 2024 C1 revenue stemming from fees paid by the pharmaceutical industry for services provided....
1. Notes that the total budget for 2024 (revenues and expenditure) amounted to EUR 478,482,000, representing a 6.8% increase compared with the 2023 budget (EUR 448,003,000)
4. Notes that, in August 2024, the ECDC activated its Public Health Emergency (PHE) plan for a period of approximately five weeks, in response to the expansion of mpox caused by MP clade II in the...
16. Encourages the recognition of additional qualifications and specialist roles to improve retention and cross-border mobility; supports the mobility of health professionals within the EU
31. Calls for greater support for general practitioners and primary care staff, recognising their role in prevention and integrated care
27. Calls for the Commission and the Member States to be systematically involved in preparedness, prevention, response and recovery measures, building on lessons learned from the COVID-19...
17. Highlights that reliance on recruitment from outside the EU should be reduced to ensure long-term sustainability
1.
13. Calls on Member States to take measures aimed at addressing
25. Supports the digitalisation of administrative processes and the introduction of smart tools to reduce administrative burdens
Content not available
AMENDMENTS 970 - 1313 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
AMENDMENTS 570 - 969 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
AMENDMENTS 970 - 1313 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
AMENDMENTS 970 - 1313 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
AMENDMENTS 970 - 1313 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
AMENDMENTS 970 - 1313 - Draft report Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
Without prejudice to the prerogatives of the Council, the Commission, shall explore possibilities of concluding strategic partnerships aiming to diversify sourcing of critical medicinal products,...
More than 12,000 decision-makers read us every morning
Start a trial10 minutes a day to master the essentials of political information.
+50 expert journalists give you early access to key information.
21 official sources scrutinised according to your topics to deliver the information that should not be missed.